ARHGEF7 |
IPI00449908 |
GIT2 |
IPI00238218 |
31.110 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
31.110 |
Evidence |
|
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
31.110 |
Evidence |
|
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
LOC389305 |
Uncharacterized protein ENSP00000349185 (Fragment) |
31.060 |
Evidence |
|
RB1 |
RB1: Retinoblastoma-associated protein |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
31.040 |
Evidence |
O
|
HSP90AB1 |
HSP90AB1, HSP90B, HSPC2, HSPCB: Heat shock protein HSP 90-beta |
HSP90AA1 |
Hsp89-alpha-delta-N |
31.040 |
Evidence |
|
JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
PKP3 |
PKP3: Plakophilin-3 |
31.040 |
Evidence |
|
EIF4G1 |
EIF4G1, EIF4F, EIF4G, EIF4GI: Eukaryotic translation initiation factor 4 gamma 1 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
31.040 |
Evidence |
|
RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
ARHGDIA |
ARHGDIA, GDIA1: Rho GDP-dissociation inhibitor 1 |
31.000 |
Evidence |
O
|
CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
CSK |
CSK: Tyrosine-protein kinase CSK |
30.910 |
Evidence |
|
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
JAK1 |
|
30.910 |
Evidence |
|
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
30.910 |
Evidence |
|
IL10RA |
IL10RA, IL10R: Interleukin-10 receptor alpha chain precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
30.910 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
30.910 |
Evidence |
|
NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
ICAM3 |
ICAM3: Intercellular adhesion molecule 3 precursor |
30.910 |
Evidence |
|
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
LYN |
LYN: Tyrosine-protein kinase Lyn |
30.910 |
Evidence |
|
CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
30.910 |
Evidence |
O
|
CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
CSK |
CSK: Tyrosine-protein kinase CSK |
30.910 |
Evidence |
|
PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
30.910 |
Evidence |
|
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
30.910 |
Evidence |
|
ORC2L |
ORC2L, ORC2: Origin recognition complex subunit 2 |
CCNB1 |
Cyclin B1 |
30.720 |
Evidence |
|
PSMD3 |
PSMD3: 26S proteasome non-ATPase regulatory subunit 3 |
PSMD7 |
PSMD7, MOV34L: 26S proteasome non-ATPase regulatory subunit 7 |
30.480 |
Evidence |
O
|
PSMD7 |
PSMD7, MOV34L: 26S proteasome non-ATPase regulatory subunit 7 |
PSMD11 |
PSMD11: 26S proteasome non-ATPase regulatory subunit 11 |
30.480 |
Evidence |
O
|
FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
30.320 |
Evidence |
|
JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
PTPRG |
PTPRG, PTPG: Receptor-type tyrosine-protein phosphatase gamma precursor |
30.320 |
Evidence |
|